Waltham Massachusetts based Regenacy Pharmaceuticals is raising $40,707,421.00 in New Equity Investment.
Waltham, MA – According to filings with the U.S. Securities and Exchange Commission, Regenacy Pharmaceuticals is raising $40,707,421.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Simon Jones…